YOLFTbeta
Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

MDGL · NASDAQ · Healthcare / Biotechnology

427.39USD+2.18 (+0.51%)

Price History

Full chart

Market Stats

Previous Close425.21
Open424.92
Day Range414.16 – 428.90
52-Week Range393.61 – 615.00
Volume441.20K
Market Cap11.93B
P/E (TTM)0.00
Forward P/E78.13
EPS-14.00
Dividend Yield0.00%
Beta-0.99
50-Day Avg527.58
200-Day Avg512.28

About

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. William J. Sibold
  • Employees915
  • Headquarters1001 Conshohocken State Road, West Conshohocken, PA, United States, 19428, USA
  • Websitehttps://www.madrigalpharma.com

Leadership

  • Mr. William J. SiboldCEO, President & Director · b. 1966
  • Dr. Rebecca A. Taub M.D.Founder, Senior Scientific & Medical Advisor and Director · b. 1952
  • Ms. Mardi C. DierExecutive VP & CFO · b. 1964
  • Ms. Shannon KelleyExecutive VP, Chief Legal Officer & Corporate Secretary · b. 1975
  • Ms. Carole HuntsmanExecutive VP & Chief Commercial Officer · b. 1965
  • Dr. David Soergel M.D.Executive VP & Chief Medical Officer · b. 1968
  • Mr. Mark UnderwoodExecutive Vice President of Business Planning & Operations
  • Ms. Rita ThakkarSenior VP & Chief Accounting Officer · b. 1974
  • Mr. Ronald FilippoExecutive VP & Chief Information Officer
  • Ms. Tina E. VenturaChief Investor Relations Officer

Financials

Income Statement

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--1.30M173.00K--743.00K2.62M144.25M14.80M7.58M147.00K0000350.00K000000180.13M958.40M
Growth (%)----86.73%---+251.95%+5416.06%-89.74%-48.77%-98.06%-100.00%-----100.00%------+432.05%
Cost of Revenue---3.13M-3.65M--3.70M-1.46M738.00K516.00K673.00K015677.00K96.00K112.00K471.00K405.00K467.00K527.00K6.23M56.15M
Gross Profit--1.30M-2.96M--3.65M743.00K2.62M140.55M14.80M6.12M-738.00K-516.00K-673.00K0-156350.00K-96.00K-112.00K-471.00K000173.90M902.25M
Gross Margin--100.00%-1709.25%--100.00%100.00%97.44%100.00%80.70%-502.04%----100.00%------96.54%94.14%
Operating Expense--29.60M42.39M-55.50M66.96M96.32M60.01M51.70M51.55M60.35M87.04M83.28M3.17M25.22M32.41M40.59M94.86M206.20M242.48M293.57M380.50M671.77M1.20B
Operating Income-401.00K-36.26M-28.29M-45.35M-71.18M-59.15M-66.22M-93.71M80.54M-36.90M-45.43M-61.09M-87.56M-83.95M-3.17M-25.22M-32.06M-40.68M-94.97M-206.67M-242.48M-293.57M-380.50M-497.88M-300.10M
Operating Margin---2169.79%-26211.56%---8911.98%-3583.48%55.84%-249.26%-599.05%-41556.46%-----9160.57%-------276.39%-31.31%
EBITDA-401.00K10.80M-27.29M-44.39M-66.41M-53.62M-60.14M-89.41M81.86M-34.97M-43.97M-60.20M-87.04M-83.28M-3.23M-25.22M-31.98M-40.59M-94.86M-206.20M-242.08M-290.92M-360.39M-450.13M-264.47M
EBITDA Margin---2092.64%-25657.23%---8094.75%-3419.20%56.75%-236.20%-579.75%-40954.42%-----9138.57%-------249.88%-27.59%
Net Income-381.00K-36.15M-27.88M-45.93M-68.86M-57.27M-63.49M-92.62M79.09M-37.47M-47.38M-62.79M-90.19M-86.16M-6.84M-26.39M-31.15M-32.81M-72.81M-197.44M-241.08M-295.35M-373.63M-465.89M-288.28M
Net Income Margin---2137.88%-26551.45%---8545.76%-3541.80%54.83%-253.10%-624.74%-42714.29%-----8901.14%-------258.64%-30.08%
R&D277.00K7.29M24.34M38.14M59.90M50.50M52.02M81.58M51.05M40.25M41.46M49.41M71.86M68.20M54.22M15.93M24.39M25.39M72.32M184.81M205.16M245.44M272.35M236.72M388.52M
R&D as % of Total Revenue--1866.33%22043.93%--7002.02%3119.73%35.39%271.92%546.73%33613.61%----6968.57%------131.41%40.54%
Interest Expense0000000489.00K312.00K569.00K1.95M1.85M2.63M2.21M1.06M1.16M558.00K7.67M11.02M4.33M1.04M3.96M12.71M14.67M22.31M
Interest Expense % of Total Revenue--0.00%0.00%--0.00%18.70%0.22%3.84%25.69%1257.82%----159.43%------8.14%2.33%

Balance Sheet

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.77M-80.39M132.02M71.21M54.79M122.65M97.25M48.91M54.07M42.32M103.02M95.20M100.67M68.19M41.21M192.31M485.43M442.06M287.00M273.33M362.57M640.55M1.04B1.26B
Total Liabilities29.00K-3.50M14.06M18.73M56.54M97.75M156.04M24.00M30.59M27.55M27.95M46.11M35.54M17.79M4.80M10.05M8.44M25.49M47.02M77.22M165.18M235.21M287.86M656.90M
Total Equity2.74M-76.89M117.96M52.48M-1.75M24.90M-58.79M24.91M23.48M14.77M75.07M49.09M65.14M50.41M36.41M182.26M476.98M416.56M239.97M196.11M197.39M405.33M754.38M602.69M
Cash--36.06M42.74M23.81M33.69M115.58M52.05M44.16M31.31M30.07M81.51M48.49M46.02M34.97M40.50M148.63M57.38M46.70M54.00M36.27M331.55M99.92M100.02M198.69M
Total Debt---1.73M6.17M5.50M5.22M10.48M2.06M11.89M16.65M12.40M23.40M13.91M4.65M---676.00K786.00K797.00K49.89M117.19M119.57M354.36M
Net Debt---36.06M-41.01M-17.64M-28.19M-110.36M-41.57M-42.09M-19.42M-13.43M-69.11M-25.09M-32.12M-30.32M-40.50M-191.53M-483.72M-46.02M-53.22M-35.47M-281.66M17.28M19.55M155.67M

Cash Flow

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-23.61M-33.80M-61.88M-52.98M27.22M-37.94M-26.81M-38.20M-47.30M-54.13M-77.41M-78.92M-71.44M-17.61M-22.32M-25.51M-41.62M-157.56M-183.92M-224.86M-324.23M-455.57M-189.55M
Investing Cash Flow-40.40M-43.81M39.18M23.57M10.79M-23.69M21.05M-19.80M9.33M-9.94M-24.65M-8.84M20.00M21.99M-22.01M-380.08M30.71M159.78M-5.05M206.69M-502.52M-274.39M32.32M
Financing Cash Flow71.12M84.28M3.78M39.29M43.88M-1.91M-2.13M45.16M36.74M115.52M69.04M85.30M40.39M14.45M173.81M314.33M235.00K5.09M171.24M313.45M595.12M735.06M255.98M
Capital Expenditure769.00K1.59M4.88M1.58M2.35M2.18M454.00K136.00K690.00K505.00K769.00K144.00K58.00K3.08K125.00K22.00K172.00K334.00K209.00K217.00K1.48M1.46M467.00K
Free Cash Flow-24.38M-35.39M-66.77M-54.56M24.87M-40.12M-27.26M-38.34M-47.99M-54.64M-78.18M-79.07M-71.50M-17.61M-22.44M-25.53M-41.80M-157.90M-184.13M-225.07M-325.71M-457.03M-190.02M
Dividends Paid---1.86M----0115.50K00000--------
FCF to OCF103.26%104.72%107.89%102.98%91.37%105.76%101.69%100.36%101.46%100.93%100.99%100.18%100.08%100.02%100.56%100.09%100.41%100.21%100.11%100.10%100.46%100.32%100.25%
Dividend Paid to FCF----3.41%----0.00%-0.21%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateMar 29, 2007May 7, 2007Aug 6, 2007Nov 13, 2007Mar 20, 2008May 14, 2008Aug 7, 2008Nov 13, 2008Mar 26, 2009May 7, 2009Aug 4, 2009Nov 4, 2009Mar 11, 2010May 4, 2010Aug 9, 2010Nov 4, 2010Mar 11, 2011May 5, 2011Aug 4, 2011Nov 3, 2011Feb 22, 2012May 3, 2012Aug 2, 2012Nov 6, 2012Mar 14, 2013Apr 30, 2013Aug 1, 2013Nov 4, 2013Mar 11, 2014May 8, 2014Aug 6, 2014Nov 6, 2014Mar 12, 2015May 7, 2015Aug 6, 2015Nov 5, 2015Mar 15, 2016May 10, 2016Jul 20, 2016Nov 14, 2016Mar 31, 2017May 11, 2017Aug 10, 2017Nov 9, 2017Mar 13, 2018May 8, 2018Aug 7, 2018Nov 6, 2018Feb 27, 2019May 8, 2019Aug 7, 2019Nov 6, 2019Feb 26, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Feb 25, 2021May 6, 2021Aug 5, 2021Nov 4, 2021Feb 24, 2022May 9, 2022Aug 4, 2022Nov 3, 2022Feb 23, 2023May 9, 2023Aug 8, 2023Nov 6, 2023Feb 28, 2024May 7, 2024Aug 7, 2024Oct 31, 2024Feb 26, 2025May 1, 2025Aug 5, 2025Nov 4, 2025Feb 19, 2026May 6, 2026Jul 30, 2026Nov 3, 2026
EPS Estimate--17.03-18.43-20.07-17.64-18.11-20.25-23.05-30.73-18.78-11.7261.25-8.61-7.35-8.05-7.70--9.74-6.79-9.97-9.35-8.63-9.30-8.28-9.15-9.36-10.32-10.72-10.50-10.03-9.33-8.46-7.28-6.87-6.36-5.60-5.60-1.05-0.70-0.35-1.39-0.87-0.60-0.79-0.70-0.77-0.62-0.53-0.74-0.97-1.22-1.42-1.65-1.95-2.43-3.30-3.85-3.94-3.54-3.85-3.88-3.54-3.64-4.18-4.61-4.94-4.54-4.93-5.34-6.28-7.66-6.91-4.12-3.79-3.53-1.99-0.60-4.14-2.551.00
EPS Actual-20.90-19.95-17.50-15.75-16.10-18.20-23.45-27.30-26.95-24.15-8.75121.80-7.35-8.40-7.70-8.75-7.48-9.45-10.50-10.50-7.70-9.45-8.75-8.75-10.15-10.50-11.55-11.55-10.85-9.80-8.40-6.65-6.65-6.65-5.25-4.55-2.80-1.75-0.70-1.59-0.67-0.50-0.69-0.68-0.67-0.45-0.45-0.56-0.75-0.98-1.28-1.39-1.80-2.34-3.18-3.75-3.82-3.32-3.72-3.79-3.78-3.36-4.14-4.75-4.98-4.23-4.69-5.34-5.68-7.38-7.10-4.92-2.71-3.32-1.90-4.96-2.57-1.38-1.99-
Surprise--17.15%5.05%21.52%8.73%-0.50%-15.80%-18.44%12.30%-28.59%25.34%98.86%14.63%-14.29%4.35%-13.64%-2.98%-54.64%-5.32%17.65%-9.50%5.91%-5.68%-10.93%-12.18%-11.92%-7.74%-3.33%2.29%9.97%21.39%8.65%3.20%17.45%18.75%50.00%-66.67%0.00%-354.29%51.80%42.53%-15.00%13.92%4.29%41.56%27.42%-5.66%-1.35%-1.03%-4.92%2.11%-9.09%-20.00%-30.86%-13.64%0.78%15.74%-5.08%1.56%2.58%5.08%-13.74%-13.64%-8.03%14.37%-3.30%-8.32%-6.37%-17.52%7.31%28.80%34.30%12.40%46.18%-149.25%-325.57%66.67%21.96%-
Timing-------------------------------Pre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap11.93B
Enterprise Value11.36B
Trailing P/E0.00
Forward P/E78.13
PEG Ratio0.00
Price / Sales9.30
Price / Book22.63
EPS-14.00
Book Value22.68
Revenue (TTM)1.28B
Gross Profit (TTM)1.17B
EBITDA-321.10M
Profit Margin-25.32%
Operating Margin-15.46%
Return on Equity-53.31%
Return on Assets-17.84%
Shares Outstanding23.10M
Shares Float13.72M
Beta-0.99
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 15 analystsTarget 682.11
  • Strong Buy
    10
  • Buy
    3
  • Hold
    1
  • Sell
    1

Ownership Breakdown

Institutions
104.47%
Insiders
5.83%
Retail / Other
0.00%

Top Institutional Holders

  • Baker Bros Advisors LP
    2.14M9.27%
  • HHG PLC
    2.02M8.74%
  • RTW INVESTMENTS, LLC
    1.99M8.63%
  • venBio Select Advisor LLC
    1.82M7.87%
  • BlackRock Inc
    1.56M6.75%
  • Paulson & Company Inc
    1.34M5.80%
  • Vanguard Portfolio Management, LLC
    841.14K3.64%
  • Vanguard Capital Management, LLC
    827.14K3.58%
  • Wellington Management Company LLP
    825.71K3.57%
  • State Street Corp
    609.52K2.64%
  • FMR Inc
    511.73K2.21%
  • Citadel Advisors Llc
    507.23K2.20%
  • Geode Capital Management, LLC
    455.87K1.97%
  • Amvescap Plc.
    329.52K1.43%
  • T. Rowe Price Associates, Inc.
    328.11K1.42%
  • William Blair Investment Management, LLC
    324.12K1.40%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    586.20K2.54%
  • Vanguard Health Care Inv
    521.93K2.26%
  • Vanguard Small Cap Index
    424.45K1.84%
  • Janus Henderson Forty S
    338.60K1.47%

Stock Splits

  • Jul 25, 20161:35